These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
49. Epidemiology and infection control of carbapenem resistant Acinetobacter baumannii and Klebsiella pneumoniae at a German university hospital: a retrospective study of 5 years (2015-2019). Chhatwal P; Ebadi E; Schwab F; Ziesing S; Vonberg RP; Simon N; Gerbel S; Schlüter D; Bange FC; Baier C BMC Infect Dis; 2021 Nov; 21(1):1196. PubMed ID: 34837973 [TBL] [Abstract][Full Text] [Related]
50. Incidence, risk factors and outcome of multi-drug resistant Acinetobacter baumannii nosocomial infections during an outbreak in a burn unit. Munier AL; Biard L; Legrand M; Rousseau C; Lafaurie M; Donay JL; Flicoteaux R; Mebazaa A; Mimoun M; Molina JM Int J Infect Dis; 2019 Feb; 79():179-184. PubMed ID: 30529108 [TBL] [Abstract][Full Text] [Related]
51. Impact of carbapenem resistance on clinical and economic outcomes among patients with Acinetobacter baumannii infection in Colombia. Lemos EV; de la Hoz FP; Alvis N; Einarson TR; Quevedo E; Castañeda C; Leon Y; Amado C; Cañon O; Kawai K Clin Microbiol Infect; 2014 Feb; 20(2):174-80. PubMed ID: 23668595 [TBL] [Abstract][Full Text] [Related]
52. [The epidemiology of multidrug-resistant bacteria colonization and analysis of its risk factors in intensive care unit]. Huang X; Li G; Yi L; Li M; Wang J Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2015 Aug; 27(8):667-71. PubMed ID: 26255016 [TBL] [Abstract][Full Text] [Related]
54. Nomogram for predicting 90-day mortality in patients with Pei Y; Huang Y; Pan X; Yao Z; Chen C; Zhong A; Xing Y; Qian B; Minhua S; Zhou T J Int Med Res; 2023 Mar; 51(3):3000605231161481. PubMed ID: 36935582 [TBL] [Abstract][Full Text] [Related]
55. The Distribution of Multidrug-resistant Microorganisms and Treatment Status of Hospital-acquired Pneumonia/Ventilator-associated Pneumonia in Adult Intensive Care Units: a Prospective Cohort Observational Study. Chang Y; Jeon K; Lee SM; Cho YJ; Kim YS; Chong YP; Hong SB J Korean Med Sci; 2021 Oct; 36(41):e251. PubMed ID: 34697926 [TBL] [Abstract][Full Text] [Related]
56. Risk Factors and Impact on Clinical Outcome of Multidrug-Resistant Acinetobacter Baumannii Acquisition in Cardiac Surgery Patients. Pierri MD; Crescenzi G; Capestro F; Recanatini C; Manso E; D'errico MM; Prospero E; Barbadoro P; Torracca L J Cardiothorac Vasc Anesth; 2016 Jun; 30(3):680-6. PubMed ID: 26718661 [TBL] [Abstract][Full Text] [Related]
57. Sulbactam combined with tigecycline improves outcomes in patients with severe multidrug-resistant Acinetobacter baumannii pneumonia. Deng Y; Chen L; Yue M; Huang X; Yang Y; Yu H BMC Infect Dis; 2022 Oct; 22(1):795. PubMed ID: 36271362 [TBL] [Abstract][Full Text] [Related]
58. Impact of environmental cleaning on the colonization and infection rates of multidrug-resistant Acinetobacter baumannii in patients within the intensive care unit in a tertiary hospital. Li Y; Ge H; Zhou H; Zhou W; Zheng J; Chen W; Cao X Antimicrob Resist Infect Control; 2021 Jan; 10(1):4. PubMed ID: 33407899 [TBL] [Abstract][Full Text] [Related]
59. Multi-drug resistant Acinetobacter species: a seven-year experience from a tertiary care center in Lebanon. Kanafani ZA; Zahreddine N; Tayyar R; Sfeir J; Araj GF; Matar GM; Kanj SS Antimicrob Resist Infect Control; 2018; 7():9. PubMed ID: 29387343 [TBL] [Abstract][Full Text] [Related]
60. Risk factors and impact of nosocomial Acinetobacter baumannii bloodstream infections in the adult intensive care unit: a case-control study. Jang TN; Lee SH; Huang CH; Lee CL; Chen WY J Hosp Infect; 2009 Oct; 73(2):143-50. PubMed ID: 19716203 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]